TFS
TVRD

TrustCore Financial Services’s Tvardi Therapeutics TVRD Stock Holding History

TrustCore Financial Services’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 1072
2021
Q3 		$0 Hold
1
– – ﹤0.01% 1168
2021
Q2 		$0 Hold
1
– – ﹤0.01% 1114
2021
Q1 		$1K Hold
1
– – ﹤0.01% 902
2020
Q4 		$0 Hold
1
– – ﹤0.01% 964
2020
Q3 		$0 Hold
1
– – ﹤0.01% 941
2020
Q2 		$0 Hold
1
– – ﹤0.01% 964
2020
Q1 		$0 Hold
1
– – ﹤0.01% 973
2019
Q4 		$0 Hold
1
– – ﹤0.01% 985
2019
Q3 		$0 Buy
+1
New +$831 ﹤0.01% 998

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

TrustCore Financial Services's TVRD Position: Q4 2021 in Review

TrustCore Financial Services sold out of Tvardi Therapeutics (TVRD) in Q4 2021, closing a stake of 1 share.

TrustCore Financial Services first reported a position in TVRD in Q3 2019 and held it in 9 quarters. The position peaked at $1K in Q1 2021. 181 funds tracked by Wall St. Rank hold TVRD as of Q4 2021.

  • TrustCore Financial Services reported no remaining Tvardi Therapeutics position as of Q4 2021 after selling out during the quarter.
  • TrustCore Financial Services sold 1 Tvardi Therapeutics share in Q4 2021.
  • TrustCore Financial Services first reported a position in Tvardi Therapeutics in Q3 2019 and held it in 9 quarters.
  • TrustCore Financial Services's Tvardi Therapeutics position peaked at $1K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2021.

Based on TrustCore Financial Services's 13F filing for Q4 2021, filed 9 Feb 2022.